Skip to content

injektionsvätska

DRUG10 trials

Sponsors

Tiohundra AB, Zealand University Hospital, Region Oerebro Laen, Vaestra Goetalandsregionen, Karolinska University Hospital, Karolinska Institutet

Conditions

Allergic rhinitis due to dog allergyAllergisk RinitBreast cancerCardiac arrestHealthy volunteersMyocardial infarctionSeriousThe ITP block is primarily used for pain amelioration after breast cancer surgery.

Phase 2

Phase 3

Phase 4

The Intertransverse Process Block for Minor Breast Cancer Surgery – Single or Multiple Injection? A randomised, procedure related, blinded clinical trial.
WithdrawnCTIS2022-501312-34-00
Zealand University HospitalBreast cancer
Target: 30Updated: 2022-10-14
The Intertransverse Process Block - Single or Multiple Injection? A randomised, procedure related, blinded crossover trial in healthy volunteers
CompletedCTIS2022-501312-34-01
Zealand University HospitalThe ITP block is primarily used for pain amelioration after breast cancer surgery.
Start: 2023-02-26End: 2023-03-08Target: 12Updated: 2023-01-24
Effect of infLuenza vaccInation after Myocardial INfArction on cardiac inflammaTory responsE - a randomized, double-blind, placebo-controlled, trial (ELIMINATE trial)
RecruitingCTIS2023-505361-86-00
Region Oerebro LaenMyocardial infarction
Start: 2024-04-12Target: 90Updated: 2025-04-29
Low-Intervention Clinical Trial Evaluating a Novel Cytokine Release Assay for Tick-Borne Encephalitis (TBE) Among Healthy and Immunosuppressed Research Participants
RecruitingCTIS2023-509575-16-00
Vaestra GoetalandsregionenTick-borne encephalitis
Start: 2024-08-19Target: 100Updated: 2025-02-07
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice - ALLERDOG SWEDEN
Not yet recruitingCTIS2024-517649-15-00
Karolinska InstitutetAllergic rhinitis due to dog allergy
Target: 40Updated: 2026-01-14
Morphine for resting breathlessness in severe illness and palliative care (MORE-B): a randomized clinical trial
Not yet recruitingCTIS2026-525838-32-00
Region Skanechronic, life-limiting disease, Serious
Target: 40Updated: 2026-06-24

Related Papers